Fantastic news that screening has begun and that we expect first patient in this quarter.
Disappointing decrease in number of shareholders (9460 last quarter down to 9279 current quarter), but also not at all surprising given current macros and state of biotech interest, which is what I attribute it to. Movements compared to the last quarter are shown below - although there is a decrease, this is again mainly at the "smaller" end of town (0-5000 category). What is clear is that the reallocation of holdings flows to the over 100,000 category. Last quarter it was 1 mill shares and this quarter 642,000 shares moving from smaller holders to larger holders - so long termers continuing to accumulate and hold, which is only a good thing for Race going forward. The conviction there grows. Onward!
19% of the total number of shareholders hold 91.9% of the value of Race(last quarter this was 91.7%).
RAC Price at posting:
96.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)